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Background: Clinical guidelines consider the concept of ‘asthma control’ as the primary goal of
asthma treatment. This study aimed to explore patients’ views of concepts that are important
for understanding and evaluating asthma control.
Methods: Patients with mild to severe asthma in four countries completed the Asthma Control
Questionnaire (ACQ) and discussed their experiences in focus groups. Clinicians evaluated
patients’ levels of asthma control based on Global Initiative for Asthma (GINA) guidelines.
Clinician- and questionnaire-based ratings of asthma control were compared. Thematic anal-
ysis was used to identify key concepts from focus group transcripts.
Results: The sample consisted of 55 patients. Classification of asthma control, based on the
ACQ, was consistent with clinician rating in 28 cases (51%). In focus groups, patients discussed
concepts related to symptoms, asthma attacks (exacerbations), activity limitations, panic/
fear, tiredness, sleep disturbances (nocturnal awakening and difficulty falling asleep), and
rescue medication use when describing asthma control. Clinical guidelines also focus on symp-
toms, activity limitations, rescue medication use, and exacerbations but, in addition include
lung function parameters. Guidelines do not take into account asthma-related panic/fear or
tiredness and sleep disturbances beyond nocturnal awakening.
Conclusion: The results of this study suggest that patients’ understanding of asthma control
extends beyond the usual clinical manifestation of respiratory symptoms and lung function.
This may have implications for clinical practice, for setting and achieving the goals of asthma
control as well as for evaluation of treatments for asthma from the patients’ perspective.
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tions based on the ACQ were consistent with the clinicianAchieving asthma control is the primary goal of asthma
treatment. The American Thoracic Society/European
Respiratory Society Taskforce defines asthma control as the
extent to which the various manifestations of asthma have
been reduced or removed by treatment and control of
expected future risk.1 The Global Initiative for Asthma
(GINA) provides “globally accepted, evidence-based
recommendations”2 for the classification and clinical
management of asthma. This paper presents the results of
a qualitative study of patient experiences and perceptions
of asthma control and discusses the consistency between
those findings, and the concepts included in these clinical
guidelines.
Methods
Data were collected from 55 adults who participated in
eight focus groups (two each in the United States [US], the
United Kingdom [UK], France, and Germany). Patients were
required to have a clinically confirmed diagnosis of asthma.
Referring clinicians were asked to indicate the patients’
level of asthma control according to the GINA guidelines.
Patients’ levels of asthma control were computed using
scores from the Asthma Control Questionnaire3 using
published guidelines.4,5 The ACQ includes participants’
reports of nighttime awakenings, symptom severity upon
awakening, activity limitation due to asthma, shortness of
breath due to asthma andwheezing, and use of a short-acting
bronchodilator over the past week. FEV1 percent predicted,
recorded by clinical staff, is also included in the score.
Focus groups were conducted in the local language, by
native language speakers using semi-structured interview
guides. Discussion topics included patients’ perceptions of
asthma control, symptoms that they experienced and asso-
ciatedwith asthmacontrol, and the impactof asthmaon their
lives. Verbatim transcripts of the focus groups (translated to
English) were analyzed for themes using Atlas.Ti software.
Results
Thirty-five of the patients were women (64%), and the mean
age was 48 years (SD Z 17, range 18e90). The clinician
ratings of asthma control did not fully match the ACQ clas-
sification of control which included patient report of aspectsTable 1 Patient and clinician ratings of asthma control.
Level of asthma control
based on ACQ cut-points
Controlled (n Z 36)
Partially controlled (n Z 15)
Uncontrolled (n Z 0)
Missing data (n Z 4)
ACQ: Asthma Control Questionnaire
Grey shaded areas represent patients and clinician agreement on levof asthma control (Table 1). Only 28 (51%) of the classifica-
rating. None of the patients considered themselves uncon-
trolled, but two patients were classified by their clinician as
uncontrolled.
Thematic analyses of the focus group data showed that
patients considered the following to evaluate the level of
their asthma control:
a) Respiratory symptoms, including “breathing problems,”
“chest discomfort,” “cough,” and “wheezing”
b) “Asthma attacks” e sudden discrete episodes of
symptoms and periods of worsened symptoms
c) “Activity limitations” e walking, climbing stairs, talk-
ing, housework, carrying things, running, and partici-
pating in active sports
d) “Tiredness”
e) “Panic/fear” related to asthma symptoms
f) “Problems with sleep” (i.e., disturbed sleep or diffi-
culty falling asleep)
g) “Rescue medication use”
All of these concepts were mentioned in several focus
groups and in all countries. Table 2 presents a comparison
of these results and concepts considered in the GINA
guidelines and ATS/ERS statement on asthma control.
Discussion
The comparison of the asthma control classification made
by clinicians and the classification based on the ACQ, and
a review of the content of patient narratives suggests that
while patient and clinical perceptions of asthma control
largely overlap, they are not consistently matched.
Agreements between classifications based on the ACQ
and clinician rating based on GINA guidelines was not high,
consistent with the findings of previous research.6 The
results of the analyses of the focus group data provide
further insights. While symptoms mentioned by patients
were similar to those in the GINA guidelines, patients also
considered panic and fear associated with asthma symp-
toms and their experience of tiredness as aspects of asthma
control. These findings are also consistent with other
patient research in asthma,7,8 which suggest the impor-
tance of patients’ emotional responses to asthma. These
symptoms are not currently included in the guidelines. In
addition, while the guidelines only considered nocturnalClinician rating of asthma control
Controlled
(n Z 26)
Partially controlled
(n Z 27)
Uncontrolled
(n Z 2)
20 16 0
5 8 2
0 0 0
1 3 0
el of asthma control 28/55 (51%) of all cases.
Table 2 Comparison of components of asthma control.
GINAa
Developed based on expert
opinion
ATS/ERS (for clinical control)b
Developed based on literature
review and expert opinion
Results of this study
Developed based on patient input
Lung functions PEF or FEV1 FEV Not mentioned
Symptoms Daytime and nighttime Symptom-free days Daytime and nighttime
Impact Level of limitation to activity Health-related quality of life Limitation of activity
Nocturnal awakening Disturbed sleep
Difficulty falling asleep
Panic and fear related to asthma
Tiredness
Use of rescue
medication
Frequency b2-agonist use (reliever-free
days and occasions/day)
Frequency
Other variables Exacerbations
(assessment of future risk)
Exacerbations (assessment
of future risk)
Asthma attacks
Hospital visits
Composite scores
Health care utilization
ATS: American Thoracic Society, ERS: European Respiratory Society, FEV1: forced expiratory volume in 1 s, GINA: Global Initiative for
Asthma, PEF: peak expiratory flow.
a GINA e Global Strategy for Asthma Management and Prevention (2009).
b Ref. 1.
Patients’ experience of asthma control and clinical guidelines 911awakenings, patients reported other problems with sleep as
characterizing poor control. Patients used the term
“asthma attacks” to describe worsening of symptoms
instead of the term “exacerbations.” Unlike the guidelines
and the ACQ, patients did not include lung function
parameters when describing their views of asthma control.
While the sample size is relatively small, this is consis-
tent with qualitative methods. The research provides
insight into the factors beyond symptoms that patients
consider important for asthma control such as emotions and
tiredness. Considerations of these the additional concepts
in assessment tools and guidelines may be important to
ensure the patients’ perspective are included in clinical
practice and there is a shared understanding of asthma
control between the patient and the clinician. This is
necessary for setting and achieving the goals of asthma
control, as well as for a comprehensive evaluation of
treatments targeting asthma control.
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